Insmed
INSM • NASDAQ
Insmed is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William H. Lewis, with a market cap of $30.9B.
CEOWilliam H. Lewis
Market Cap$30.9B
Biotechnology
Healthcare
Employees912.0
Websiteinsmed.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Insmed
Date
Thursday, May 7, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.00
Revenue Estimate
$300.2M
Earnings History
Past 12 earnings reports for Insmed
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 19, 2026 | Q4 2025 | -$1.54Est: -$1.13 | -36.3% | $263.8MEst: $263.9M | -0.0% |  10-K |
| Oct 30, 2025 | Q3 2025 | -$1.75Est: -$1.35 | -29.6% | $142.3MEst: $115.2M | +23.6% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$1.70Est: -$1.31 | -29.8% | $107.4MEst: $104.0M | +3.3% | 10-Q |
| May 8, 2025 | Q1 2025 | -$1.42Est: -$1.36 | -4.4% | $92.8MEst: $92.1M | +0.8% | 10-Q |
| Feb 20, 2025 | Q4 2024 | -$1.32Est: -$1.16 | -13.8% | $104.4MEst: $102.3M | +2.1% | 10-K |
| Oct 31, 2024 | Q3 2024 | -$1.27Est: -$1.22 | -4.1% | $93.4MEst: $93.0M | +0.4% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$1.94Est: -$1.27 | -52.8% | $90.3MEst: $88.0M | +2.7% | 10-Q |
| May 9, 2024 | Q1 2024 | -$1.06Est: -$1.23 | +13.8% | $75.5MEst: $78.6M | -3.9% | 10-Q |
| Feb 22, 2024 | Q4 2023 | -$1.28Est: -$1.15 | -11.3% | $83.7MEst: $82.8M | +1.1% | 10-K |
| Oct 26, 2023 | Q3 2023 | -$1.11Est: -$1.12 | +0.9% | $79.1MEst: $79.1M | -0.1% | 10-Q |
| Aug 3, 2023 | Q2 2023 | -$1.78Est: -$1.10 | -61.8% | $77.2MEst: $70.3M | +9.9% | — |
| May 4, 2023 | Q1 2023 | -$1.17Est: -$1.11 | -5.4% | $65.2MEst: $64.5M | +1.1% | — |